Loading...

KP Tissue

TSX:KPT
Snowflake Description

Mediocre balance sheet unattractive dividend payer.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
KPT
TSX
CA$83M
Market Cap
  1. Home
  2. CA
  3. Household
Company description

KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in North America. The last earnings update was 43 days ago. More info.


Add to Portfolio Compare Print
KPT Share Price and Events
7 Day Returns
0.2%
TSX:KPT
1.5%
North America Household Products
0.6%
CA Market
1 Year Returns
-20.9%
TSX:KPT
34.2%
North America Household Products
3.6%
CA Market
KPT Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
KP Tissue (KPT) 0.2% -1.4% -5.8% -20.9% -32.8% -45.1%
North America Household Products 1.5% 3.4% 14.2% 34.2% 28.9% 36.8%
CA Market 0.6% 1.9% 8.1% 3.6% 14.8% 6.7%
1 Year Return vs Industry and Market
  • KPT underperformed the Household Products industry which returned 34.2% over the past year.
  • KPT underperformed the Market in Canada which returned 3.6% over the past year.
Price Volatility
KPT
Industry
5yr Volatility vs Market
Related Companies

KPT Value

 Is KP Tissue undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for KP Tissue. This is due to cash flow or dividend data being unavailable. The share price is CA$8.74.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for KP Tissue's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are KP Tissue's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
TSX:KPT PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in CAD CA$-0.02
TSX:KPT Share Price ** TSX (2019-04-18) in CAD CA$8.74
North America Household Products Industry PE Ratio Median Figure of 8 Publicly-Listed Household Products Companies 25.08x
Canada Market PE Ratio Median Figure of 554 Publicly-Listed Companies 15.17x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of KP Tissue.

TSX:KPT PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSX:KPT Share Price ÷ EPS (both in CAD)

= 8.74 ÷ -0.02

-470.85x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • KP Tissue is loss making, we can't compare its value to the North America Household Products industry average.
  • KP Tissue is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does KP Tissue's expected growth come at a high price?
Raw Data
TSX:KPT PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -470.85x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 4 Analysts
Not available
North America Household Products Industry PEG Ratio Median Figure of 6 Publicly-Listed Household Products Companies 4.56x
Canada Market PEG Ratio Median Figure of 254 Publicly-Listed Companies 1.22x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for KP Tissue, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on KP Tissue's assets?
Raw Data
TSX:KPT PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in CAD CA$10.50
TSX:KPT Share Price * TSX (2019-04-18) in CAD CA$8.74
North America Household Products Industry PB Ratio Median Figure of 13 Publicly-Listed Household Products Companies 1.91x
Canada Market PB Ratio Median Figure of 2,370 Publicly-Listed Companies 1.51x
TSX:KPT PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSX:KPT Share Price ÷ Book Value per Share (both in CAD)

= 8.74 ÷ 10.50

0.83x

* Primary Listing of KP Tissue.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • KP Tissue is good value based on assets compared to the North America Household Products industry average.
X
Value checks
We assess KP Tissue's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Household Products industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Household Products industry average (and greater than 0)? (1 check)
  5. KP Tissue has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

KPT Future Performance

 How is KP Tissue expected to perform in the next 1 to 3 years based on estimates from 4 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
5.8%
Expected Household Products industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is KP Tissue expected to grow at an attractive rate?
  • Unable to compare KP Tissue's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare KP Tissue's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare KP Tissue's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
TSX:KPT Future Growth Rates Data Sources
Data Point Source Value (per year)
North America Household Products Industry Earnings Growth Rate Market Cap Weighted Average 5.8%
North America Household Products Industry Revenue Growth Rate Market Cap Weighted Average 3.5%
Canada Market Earnings Growth Rate Market Cap Weighted Average 18.4%
Canada Market Revenue Growth Rate Market Cap Weighted Average 7.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
TSX:KPT Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
TSX:KPT Future Estimates Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2020-12-31 1,459 69 4
2019-12-31 1,430 46 3
TSX:KPT Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2018-12-31 0 0
2018-09-30 0 -7
2018-07-01 0 -6
2018-04-01 0 -6
2017-12-31 0 -5
2017-09-24 0 -2
2017-06-25 0 -1
2017-03-26 0 -1
2016-12-31 0 -2
2016-09-25 0 -29
2016-06-26 0 -32
2016-03-27 0 -32

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if KP Tissue is high growth as no earnings estimate data is available.
  • Unable to determine if KP Tissue is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
TSX:KPT Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below

All data from KP Tissue Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSX:KPT Future Estimates Data
Date (Data in CAD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2020-12-31
2019-12-31
TSX:KPT Past Financials Data
Date (Data in CAD Millions) EPS *
2018-12-31 -0.02
2018-09-30 -0.78
2018-07-01 -0.70
2018-04-01 -0.62
2017-12-31 -0.59
2017-09-24 -0.18
2017-06-25 -0.09
2017-03-26 -0.09
2016-12-31 -0.19
2016-09-25 -3.23
2016-06-26 -3.55
2016-03-27 -3.60

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • KP Tissue is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess KP Tissue's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the North America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the North America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
KP Tissue has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

KPT Past Performance

  How has KP Tissue performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare KP Tissue's growth in the last year to its industry (Household Products).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • KP Tissue does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare KP Tissue's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare KP Tissue's 1-year growth to the North America Household Products industry average as it is not currently profitable.
Earnings and Revenue History
KP Tissue's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from KP Tissue Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSX:KPT Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 -0.17
2018-09-30 -7.22
2018-07-01 -6.46
2018-04-01 -5.72
2017-12-31 -5.44
2017-09-24 -1.63
2017-06-25 -0.79
2017-03-26 -0.81
2016-12-31 -1.72
2016-09-25 -29.09
2016-06-26 -31.84
2016-03-27 -32.19
2015-12-31 -31.34
2015-09-27 -4.82
2015-06-28 -2.15
2015-03-29 -1.47
2014-12-31 -2.52
2014-09-28 -1.98
2014-06-29 -2.15
2014-03-30 -1.28
2013-12-31 -0.29
2013-09-29 -7.55
2012-12-31 -3.36
2012-09-23 5.27

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if KP Tissue has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if KP Tissue has efficiently used its assets last year compared to the North America Household Products industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if KP Tissue improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess KP Tissue's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Household Products industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
KP Tissue has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

KPT Health

 How is KP Tissue's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up KP Tissue's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • KP Tissue is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • KP Tissue's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of KP Tissue's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • KP Tissue has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from KP Tissue Company Filings, last reported 3 months ago.

TSX:KPT Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 98.77 0.00
2018-09-30 96.06 0.00
2018-07-01 96.71 0.00
2018-04-01 98.08 0.00
2017-12-31 96.93 0.00
2017-09-24 102.64 0.00
2017-06-25 108.49 0.00
2017-03-26 112.72 0.00
2016-12-31 115.08 0.00
2016-09-25 107.14 0.00
2016-06-26 109.96 0.00
2016-03-27 117.61 0.00
2015-12-31 125.22 0.00
2015-09-27 150.35 0.00
2015-06-28 148.43 0.00
2015-03-29 149.07 0.00
2014-12-31 150.60 0.00
2014-09-28 150.31 0.00
2014-06-29 148.91 0.00
2014-03-30 157.04 0.00
2013-12-31 157.97 0.00
2013-09-29 156.13 0.00
2012-12-31 139.60 0.00
2012-09-23 140.00 0.00
  • KP Tissue has no debt.
  • KP Tissue has not taken on any debt in the past 5 years.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Information is not available.
  • Unable to confirm if KP Tissue has at least 1 year of cash runway based on growing free cash flows without relevant data.
X
Financial health checks
We assess KP Tissue's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. KP Tissue has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

KPT Dividends

 What is KP Tissue's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
8.24%
Current annual income from KP Tissue dividends. Estimated to be 8.24% next year.
If you bought CA$2,000 of KP Tissue shares you are expected to receive CA$165 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • KP Tissue's pays a higher dividend yield than the bottom 25% of dividend payers in Canada (2.05%).
  • KP Tissue's dividend is above the markets top 25% of dividend payers in Canada (5.56%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
TSX:KPT Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
North America Household Products Industry Average Dividend Yield Market Cap Weighted Average of 8 Stocks 2.7%
Canada Market Average Dividend Yield Market Cap Weighted Average of 331 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.2%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

TSX:KPT Future Dividends Estimate Data
Date (Data in CA$) Dividend per Share (annual) Avg. No. Analysts
2020-12-31 0.72 2.00
2019-12-31 0.72 2.00
TSX:KPT Past Annualized Dividends Data
Date (Data in CA$) Dividend per share (annual) Avg. Yield (%)
2019-03-07 0.720 8.143
2018-08-09 0.720 8.265
2018-03-08 0.720 6.795
2017-11-08 0.720 5.317
2017-08-09 0.720 4.841
2017-05-04 0.720 4.906
2017-03-09 0.720 4.609
2016-11-03 0.720 4.718
2016-08-10 0.720 5.172
2016-05-05 0.720 5.711
2016-03-10 0.720 5.568
2015-08-12 0.720 5.884
2015-05-07 0.720 4.759
2015-03-12 0.720 4.461
2014-11-12 0.720 4.211
2014-08-13 0.720 4.509
2014-05-09 0.720 4.522
2014-03-19 0.720 4.501
2013-11-13 0.720 4.220
2013-08-13 0.720 4.172
2013-05-14 0.720 4.191
2013-03-27 0.720 3.811

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Whilst dividend payments have been stable, KP Tissue has been paying a dividend for less than 10 years.
  • KP Tissue has only been paying a dividend for 6 years, and since then there has been no growth.
Current Payout to shareholders
What portion of KP Tissue's earnings are paid to the shareholders as a dividend.
  • The company is paying a dividend however it is incurring a loss.
Future Payout to shareholders
  • Dividends after 3 years are not well covered by earnings (0.5x coverage).
X
Income/ dividend checks
We assess KP Tissue's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can KP Tissue afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. KP Tissue has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

KPT Management

 What is the CEO of KP Tissue's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Dino Bianco
AGE 56
TENURE AS CEO 1.1 years
CEO Bio

Mr. Dino J. Bianco has been a Director of Welbilt, Inc. (formerly known as Manitowoc Foodservice, Inc.) since May 2015. He served as an Executive Vice President at Kraft Foods Group, Inc., from 2012 to April 2015 and served as its President of Beverages from 2013 to April 2015. Mr. Bianco has served as Chief Executive Officer of KP Tissue Inc. and Kruger Products L.P. since March 9, 2018 and also serves as a Director of KPGP, Inc., the general Partner of Kruger Products L.P. Mr. Bianco served as President of Beverages and Canada at Kraft Foods Group, Inc., since January 2013. Mr. Bianco served as President of National Businesses & Marketing Services at Kraft Foods Group, Inc. since October 1, 2012. He leads Kraft’s Foodservice, Canada, Marketing Services and Export organizations. He served as the President at Kraft Canada, Inc. since November 2005. Prior to that, he served as Senior Vice President and General Manager of Kraft Canada Inc since November 2005. He is a director of MTW from 2015. He has more than 15 years of experience with Kraft and has held senior positions in Finance, Sales and Marketing, including Vice President, Beverages and Cereal, Kraft Canada. He served as Vice President of Mondelez International, Inc. (alternate name Kraft Foods Inc.). He began his career at Kraft as a finance manager in 1990 after spending three years at PriceWaterhouseCoopers. His extensive multifunctional background positions him well to lead the Canadian business, including overseeing local marketing and programming, building sales partnerships, managing government and public affairs issues and guiding talent management in Canada. He served as Director of Andrew Peller Limited from October 1, 2016 to January 15, 2018. He served as an Independent Director of The Manitowoc Company, Inc. until March 4, 2016. He is a past chair and Board Member of the Food and Consumer Products of Canada and Global Standards 1 Canada. He was past chair of Food and Consumer Products of Canada, past member of the Board of The Grocery Foundation and past member of the Board of Trustees of the United Way of Toronto. Mr. Bianco is a chartered accountant and received his Bachelor of Commerce degree from the University of Toronto.

CEO Compensation
  • Insufficient data for Dino to compare compensation growth.
  • Insufficient data for Dino to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
Management Team Tenure

Average tenure of the KP Tissue management team in years:

5.8
Average Tenure
  • The average tenure for the KP Tissue management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Dino Bianco

TITLE
Chief Executive Officer
AGE
56
TENURE
1.1 yrs

Mark Holbrook

TITLE
Chief Financial Officer
COMPENSATION
CA$573K

Marc Fitzgerald

TITLE
Corporate Vice President of Technology & Product Development - Kruger Products LP
TENURE
5.8 yrs

Mike Baldesarra

TITLE
Director of Investor Relations
TENURE
7.3 yrs

François Paroyan

TITLE
General Counsel & Corporate Secretary

Rob Latter

TITLE
Senior VP & GM of Away from Home Business - Kruger Products LP
COMPENSATION
CA$650K
TENURE
0.9 yrs

Michel Manseau

TITLE
Senior VP & GM of Consumer Business Canada - Kruger Products LP
COMPENSATION
CA$595K
TENURE
11.9 yrs

Nancy Marcus

TITLE
Chief Marketing Officer of Kruger Products L.P.
COMPENSATION
CA$606K
TENURE
0.9 yrs

Gordon Goss

TITLE
Senior VP and GM of Consumer Business USA & Mexico - Kruger Products LP
COMPENSATION
CA$712K
TENURE
8.2 yrs
Board of Directors Tenure

Average tenure of the KP Tissue board of directors in years:

3.3
Average Tenure
  • The tenure for the KP Tissue board of directors is about average.
Board of Directors

Michael Korenberg

TITLE
Chairman
COMPENSATION
CA$88K
AGE
57

Joseph Kruger

TITLE
Chairman of Kruger Products G.P.

Michel Letellier

TITLE
Independent Director
COMPENSATION
CA$76K
AGE
53
TENURE
6.5 yrs

Jim Hardy

TITLE
Independent Director
COMPENSATION
CA$88K
TENURE
4.8 yrs

Louise Denys Wendling

TITLE
Director
TENURE
0.9 yrs

David Angel

TITLE
Director of Kruger Products G.P

Gene Kruger

TITLE
Director of Kruger Products G.P.
TENURE
1.7 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
20. Dec 18 Buy Michel Letellier Individual 19. Dec 18 19. Dec 18 1,780 CA$7.85 CA$13,973
18. Dec 18 Sell Mario Gosselin Individual 18. Dec 18 18. Dec 18 -10,000 CA$8.07 CA$-80,150
29. Nov 18 Buy Michel Manseau Individual 27. Nov 18 27. Nov 18 1,000 CA$8.44 CA$8,440
27. Nov 18 Buy David Angel Individual 27. Nov 18 27. Nov 18 837 CA$8.35 CA$6,989
23. Nov 18 Buy David Angel Individual 22. Nov 18 23. Nov 18 1,060 CA$8.55 CA$8,934
22. Nov 18 Buy Gene Kruger Individual 22. Nov 18 22. Nov 18 11,800 CA$8.75 CA$101,200
29. Aug 18 Buy Joseph Kruger Individual 28. Aug 18 28. Aug 18 5,000 CA$9.89 CA$49,426
28. Aug 18 Buy David Angel Individual 27. Aug 18 27. Aug 18 600 CA$9.80 CA$5,880
21. Aug 18 Buy Joseph Kruger Individual 21. Aug 18 21. Aug 18 5,500 CA$10.09 CA$55,159
21. Aug 18 Buy Michael Korenberg Individual 20. Aug 18 20. Aug 18 5,000 CA$10.00 CA$49,514
X
Management checks
We assess KP Tissue's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. KP Tissue has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

KPT News

Simply Wall St News

KP Tissue Inc. (TSE:KPT) Insiders Increased Their Holdings

But logic dictates you should pay some attention to whether insiders are buying or selling shares. … The Last 12 Months Of Insider Transactions At KP Tissue. … These transactions suggest that insiders have considered the current price of CA$8.99 attractive.

Simply Wall St -

Does Market Volatility Impact KP Tissue Inc.'s (TSE:KPT) Share Price?

Some investors use beta as a measure of how much a certain stock is impacted by market risk (volatility). … While we should keep in mind that Warren Buffett has cautioned that 'Volatility is far from synonymous with risk', beta is still a useful factor to consider. … A stock with a beta below one is either less volatile than the market, or more volatile but not corellated with the overall market.

Simply Wall St -

Did KP Tissue Inc. (TSE:KPT) Insiders Buy Up More Shares?

We often see insiders buying up shares in companies that perform well over the long term. … So we'll take a look at whether insiders have been buying or selling shares in KP Tissue Inc. … But logic dictates you should pay some attention to whether insiders are buying or selling shares.

Simply Wall St -

Does KP Tissue Inc (TSE:KPT) Have A Particularly Volatile Share Price?

In finance, Beta is a measure of volatility. … Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. … Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility).

Simply Wall St -

Who Are The Top Investors In KP Tissue Inc (TSE:KPT)?

In this article, I'm going to take a look at KP Tissue Inc’s (TSE:KPT) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject among investors. … Ownership structure has been found to have an impact on shareholder returns in both short- and long-term. … While these are more of a long-term investor’s concern, short-term investors may find the impact of institutional trading overwhelming enough to lose out on what could be a potential opportunity.

Simply Wall St -

What Is KP Tissue Inc's (TSE:KPT) Share Price Doing?

saw significant share price volatility over the past couple of months on the TSX, rising to the highs of CA$10.77 and falling to the lows of CA$9.6. … A question to answer is whether KP Tissue's current trading price of CA$10.46 reflective of the actual value of the? … Let’s take a look at KP Tissue’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change

Simply Wall St -

KP Tissue Inc (TSE:KPT): Are Analysts Optimistic?

Many investors are wondering the rate at which KPT will turn a profit, with the big question being “when will the company breakeven?” I’ve put together a brief outline of industry analyst expectations for KPT, its year of breakeven and its implied growth rate. … Working backwards from analyst estimates, it turns out that they expect the company to grow 111.48% year-on-year, on average, which signals high confidence from analysts. … TSX:KPT Past Future Earnings May 13th 18 Given this is a high-level overview, I won’t go into detail the detail of KPT’s upcoming projects, however, bear in mind that by and large a high forecast growth rate is not unusual for a company that is currently undergoing an investment period.

Simply Wall St -

What Is KP Tissue Inc's (TSE:KPT) Share Price Doing?

A question to answer is whether KP Tissue's current trading price of CA$10.59 reflective of the actual value of the small-cap? … Great news for investors – KP Tissue is still trading at a fairly cheap price. … My valuation model shows that the intrinsic value for the stock is CA$82.9, but it is currently trading at CA$10.59 on the share market, meaning that there is still an opportunity to buy now.

Simply Wall St -

Read This Before Buying KP Tissue Inc (TSE:KPT) For Its Upcoming $0.18 Dividend

Check out our latest analysis for KP Tissue Here's how I find good dividend stocks If you are a dividend investor, you should always assess these five key metrics: Is it the top 25% annual dividend yield payer? … But if you are not exclusively a dividend investor, the stock could still be an interesting investment opportunity. … Given that this is purely a dividend analysis, you should always research extensively before deciding whether or not a stock is an appropriate investment for you.

Simply Wall St -

Should You Buy KP Tissue Inc (TSX:KPT) At $13.71?

According to my valuation, the intrinsic value for the stock is CA$98.06, which is above what the market is valuing the company at the moment. … This means that if you believe the current share price should move towards its intrinsic value over time, a low beta could suggest it is not likely to reach that level anytime soon, and once it’s there, it may be hard to fall back down into an attractive buying range again. … The best type of investment is always in a great company, producing robust returns at a cheap price.

Simply Wall St -

KPT Company Info

Description

KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in North America. The company operates through three segments: Consumer Products, Away-From-Home, and Other. It offers bathroom and facial tissues, paper towels, and paper towels and napkins, as well as disposable wiping products and washroom dispensing systems. The company markets its products under the Cashmere, Purex, SpongeTowels, Scotties, White Swan, and White Cloud brand names. It sells its products to end-consumers through traditional retail channels, such as grocery stores, mass merchandisers, club and drug stores, and convenience stores; and commercial users in property management, healthcare, food services, manufacturing, education, and lodging industries, as well as in public facilities. KP Tissue Inc. was founded in 2012 and is headquartered in Mississauga, Canada.

Details
Name: KP Tissue Inc.
KPT
Exchange: TSX
Founded: 2012
CA$82,807,261
9,474,515
Website: http://kptissueinc.com
Address: KP Tissue Inc.
1900 Minnesota Court,
Suite 200,
Mississauga,
Ontario, L5N 5R5,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSX KPT Common Shares The Toronto Stock Exchange CA CAD 13. Dec 2012
OTCPK KPTS.F Common Shares Pink Sheets LLC US USD 13. Dec 2012
DB KP8 Common Shares Deutsche Boerse AG DE EUR 13. Dec 2012
Number of employees
Current staff
Staff numbers
0
KP Tissue employees.
Industry
Household Products
Household
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/19 00:36
End of day share price update: 2019/04/18 00:00
Last estimates confirmation: 2019/04/17
Last earnings filing: 2019/03/07
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.